Co-Located Conference AgendasDrug Discovery and Development India | MedChem India | NanoPharmaceuticals | 
Thursday, 10 September 201508:00 | Registration | 09:00 | Inauguration | |
SESSION 1: NanoPharmaceuticals for Cancer (Session Chair: Ahmed Faheem, Senior Lecturer in Pharmaceutics, University of Sunderland, United Kingdom) |
| | 09:15 |  | Keynote Presentation Nanotechnology and Cancer- Where Are We Going
Mandip S Sachdeva, Professor, Florida A&M University, United States of America
|
| 10:00 | Nanotechnology for the Treatment of Lung Cancer: The Future of Targeted Therapy
G Praveen Kumar, Professor & Principal, Sahasra Institute of Pharmaceutical Sciences, India
This presentation will give a brief account of the targeted novel systems for lung cancer. It will discuss regarding the encapsulation of paclitaxel in nanosystem and how through this volume of distribution is significantly reduced and the concentration of drug in the lungs is significantly increased, resulting in a decrease in the amount and types of non-specific toxicities and an increase in the amount of drug that can be effectively delivered to the lung tumor. | 10:35 |  | Keynote Presentation Nanopharmaceuticals Approaches with Locked Nucleic Acid Aptamers in Cancer
Jagat Kanwar, Professor, Deakin University, Australia
This Presentation will discuss regarding the role of P-glycoprotein, Survivin and CD133 positive cancer stem cells for
enhancing Cancer resistance, promoting Cancer
Survival and recurrence. Further, it will also highlight the delivery of Fe-bLF-ACSC NanoCarriers, oligo LNA siRNA, Nanoparticles loaded with SR9
and LNAsiRNA-5-FU to target and inhibit survivin which has a direct inhibitory
effect on p-gp and CD133 CSCs.
|
| 11:20 | Coffee Break and Networking Session | |
SESSION 2: Nanotechnology based Drug Delivery Systems (Anand K. Kondapi, Professor, University of Hyderabad, India) |
| | 11:50 | Ocular Delivery to the Posterior Eye using a Novel Nanolipo-Polymeric System
Indu Pal Kaur, Professor , Panjab University, India
In the
first part of the talk, uptake and clearance pathways in the eye will be
discussed. Next part will include discussion on the use of nanostructured systems
to defy the existing ocular barriers so as to reach the internal eye including
the retina. Last part will focus on how they have developed a novel
nanolipo-polymeric system (IPA: 2074/Del/2014), which could reach up to the
retina in an intact form. | 12:25 |  | Keynote Presentation To Be Finalized
Ahmed Faheem, Senior Lecturer in Pharmaceutics, University of Sunderland, United Kingdom
|
| 13:10 | Lunch Break and Networking Session | |
SESSION 3: Nanoparticles for Drug Delivery (Session Chair: Arabinda Chaudhuri, Chief Scientist, CSIR-IICT, India) |
| | 14:10 | Lipid NanoParticle Drug Delivery Systems
Venkateswarlu Vobalaboina, Managing Director, Neuheit Pharma Technologies Pvt Ltd, India
The presentation covers, selection of formulation ingredients,
different methods of preparation of lipid nanoparticles, inclusion of homing
devices to achieve targeted drug delivery, characterization of Nano systems,
assessment of performance of nanoparticles and applications in pharmaceutical
industry.Discussion on specific problems association with formulation, stabilization
and manufacturing of these dosage forms will also be presented. Further,
regulatory requirements, Quality control, intellectual property and
manufacturing issues of NDDS will be presented. Finally, discussion on future
research areas and potential of lipid nanoparticle drug delivery systems in
industrial applications is presented. | 14:45 | Splenotropic Lipomer: Enabling Shape Directed Selective RES Targetting
Padma Devarajan, Head/Professor, Institute of Chemical Technology, India
This presentation will present how Asymmetric LIPOMER- lipid
polymer nanostructures of Doxycycline hydrochloride helps in Splenotropic
Delivery. In addition, it will also highlight the process of design and
development of Asymmetric LIPOMER by Nanoprecipitation technique. Further,
it will discuss the role of nanocarrier shape as an important parameter
in Drug Delivery. | 15:20 | The Role of Nanoparticle Constructs in Lung and Breast Cancer
Mandip S Sachdeva, Professor, Florida A&M University, United States of America
| 15:55 | Coffee Break and Networking Session | |
SESSION 4: Nanoformulations for Effective Drug Delivery |
| | 16:25 | Targeted Drug Delivery System through Nanoformulations
Palanivel Venkatesan, Assistant Professor, Annamalai University , India
This presentation will discuss the broad treatment of solid lipid nanoparticles discussing their advantages, limitations and their possible remedies. The different types of Nano carriers, solid lipid nanoparticles, nanostructured lipid carriers, lipid drug conjugates are discussed with their structural differences. | 16:50 | Targeted Drug Delivery to Lung Cancer with Surface Modified and Antibody – Functionalized Chitosan Nanoparticles
Asha Srinivasan, MSc Course Coordinator , Jagadguru Sri Shivarathreeswara University, India
This talk will focus on targeted delivery of Drug Loaded Chitosan
Nanoparticles surface modified with Trastuzumab to the Lung Cancer Cells.
Further, it will discuss how these Nanoparticles were functionalized,
characterized and kinetics elucidated in vitro using different Lung Cancer Cells. | 17:15 | Solubility Enhancement and Formulation of Nanoparticles of Efavirenz using Chitosan-Graft-HPßCD copolymer
Aarti Belgamwar, Research Scholar, Institute of Pharmaceutical Education and Research, India
The
present study will explore a novel method for solubility enhancement of water
insoluble antiretroviral drug Efavirenz by using chitosan –graft-HPßCD
copolymer synthesized by simplified one pot reaction technique and further its
application as carrier for formulation of nanoparticles. | 17:30 | End of First Day of Conference |
Friday, 11 September 2015 |
SESSION 5: Nanotechnology Solutions for Drug Delivery Challenges (Session Chair: Utpal Bhadra, Senior Principal Scientist, CSIR-CCMB, India) |
| | 09:00 |  | Keynote Presentation Structuring Nanocarriers for Site Directed Drug Delivery
Suresh P Vyas, Professor, Dr Harisingh Gour University, India
In this Keynote Presentation, Challenges and Solutions for
Engineering of Nanoparticles for improving biodegradability, release rate and
targeting of Drugs will be discussed. Further, it will highlight the features
of nanotechnology-based carrier systems in terms of size and structure, precise
scaffolding for attachment of Drugs which helps in targeting of potent
bioactive compounds at a pre selected target site, ensuring their effectiveness
and safety in the clinical use. |
| 09:45 |  | Keynote Presentation NanoPharmaceuticals: Overcoming Drug Delivery Challenges
Kamalinder Singh, Professor, University of Central Lancashire, United Kingdom
|
| 10:30 | Coffee Break and Networking Session | |
SESSION 6: Advances in Nanotherapeutics |
| | 11:00 | Advanced Nanomaterials for Future Therapeutics
Chittaranjan Patra, Scientist & Ramanujan Fellow (DST, New Delhi) , Indian Institute of Chemical Technology, India
This presentation will highlight the advanced
nanomaterials and nanoparticles based drug delivery systems (DDS) for treatment
of cancer, cardiovascular /ischemic disease and wound healing. It will further
highlight the design and development of nanoparticles like europium hydroxide
nanorods (EHNs), zinc oxide nanoflowers (ZON), graphene oxides and gold
nanoparticles that exhibit excellent pro-angiogenic activities. | 11:35 |  | Keynote Presentation Advanced Medical Applications of Nanotechnology
Kewal Jain, Chief Executive Officer/Professor, Jain Pharma Biotech, Switzerland
This presentation will deal with advances in nanomedicine with
emphasis on improvement in drug delivery and applications in cancer and
neurological disorders. It will also explain how biotechnology with facilitate
the development of personalized medicine. |
| 12:20 | | 13:05 | Poster Evaluation | 13:20 | Lunch Break and Networking Session | |
SESSION 7: NanoPharmaceuticals for Biologicals and Gene Therapy (Session Chair: Kewal Jain, Chief Executive Officer, Jain PharmaBiotech, Switzerland) |
| | 14:20 | Dual Drug Combination Therapy: Current Prospective and Future Challenges
Preeti Nigam Joshi, INSPIRE Faculty, National Chemical Laboratory, India
The
presenter will discuss the combinatorial liposomal nanoformulation for
pancreatic cancer based on gemcitabine and ursolic acid, along with the
advantages and future prospective of combinatorial dual drug therapy. | 14:45 |  | Keynote Presentation Para Amino Benzoic Acid derived Self Assembled Biocompatible Nanoparticle for Efficient Delivery of siRNA
Manika Pal Bhadra, Principal Scientist, Indian Institute of Chemical Technology, India
The Keynote Talk will discuss the development of functionalized biocompat¬ible fluorescent nanoparticles from para amino benzoic acid nanoparticles for efficient delivery of short interfering RNA (siRNA). Further, it will report that these nanoparticles are non-toxic and did not interfere with progression of the cell cycle. Finalli, it will highlight that the intrinsic fluorescent nature of these nanoparticles allows easy tracking and an opportunity for diagnostic applications. |
| 15:30 | Nanotechnology Based Growth Factors Delivery for Tissue Regeneration
Jyotsnendu Giri, Assistant Professor, Indian Institute of Technology, Hyderabad, India
This
talk will cover the development of novel nanoencapsulation of protein in to
sugar-glass-matrix (SGnP) to overcome the formidable challenges of Growth
Factors stabilization and their sustained delivery. | 16:05 | Coffee Break and Networking Session | |
SESSION 8: Overcoming Pharmaceutical Issues with Nanoformulations |
| | 16:30 | Biodegradable Polymer Based Depot Injections – Overview and Challenges - Case Studies of Marketed Products
Dhiraj Chopra, Associate Director, Dr Reddys Laboratories Limited, India
This talk will present the development and scale-up of Biodegradable Polymer based Depot Injections. Further, it will discuss the processing of microspheres based formulations using various solvent casting techniques, involving complex & multiple unit operations. Finally, it will highlight the scale up of such biodegradable polymer based depot injection under aseptic conditions. | 17:05 | Novel, Industrially Feasible Nanocoformulation of Artemether and Clindamycin for Treatment of Malaria in Pregnant Women: A Selective Second Order Targeting Approach
Sudeep Pukale, Student, Institute of Chemical Technology, India
| 17:20 | Poster Award Presentation & Vote of Thanks | 17:30 | End of Conference |
|
.jpg)
Add to Calendar ▼2015-09-10 00:00:002015-09-11 00:00:00Europe/LondonNanoPharmaceuticalsNanoPharmaceuticals in HyderabadHyderabadSELECTBIOenquiries@selectbiosciences.com
